Safe Use of Metformin in Mitochondrial Diabetes: Response to Letter to Editor
AACE Endocrinology and Diabetes · 2026-03 · 13 (2) · 270
DOI: 10.1016/j.aed.2026.01.009 ↗Kurz gefasst
Leserbrief in der Zeitschrift AACE Endocrinology and Diabetes, 2026-03. Verfasst von Thanisha Santhosh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Mayo Clinic, Rochester, Minnesota. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 2 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Endocrinology, Mayo Clinic, Rochester, Minnesota.
- Division of Endocrinology, Mayo Clinic, 200 First St SW, Rochester, MN 55905.
Zitieren
APA
Santhosh, T., Ramamurthy, P., & Simha, V. (2026). Safe Use of Metformin in Mitochondrial Diabetes: Response to Letter to Editor. AACE Endocrinology and Diabetes, 13(2), 270. https://doi.org/10.1016/j.aed.2026.01.009
Vancouver
Santhosh T, Ramamurthy P, Simha V. Safe Use of Metformin in Mitochondrial Diabetes: Response to Letter to Editor. AACE Endocrinology and Diabetes. 2026;13(2):270. doi:10.1016/j.aed.2026.01.009
BibTeX
@article{Santhosh2026,
author = {Santhosh, Thanisha and Ramamurthy, Prakriti and Simha, Vinaya},
title = {Safe Use of Metformin in Mitochondrial Diabetes: Response to Letter to Editor},
journal = {AACE Endocrinology and Diabetes},
year = {2026},
volume = {13},
number = {2},
pages = {270},
doi = {10.1016/j.aed.2026.01.009}
}
EUVIMED